Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes

Journal Title: Turkish Journal of Neurology - Year 2020, Vol 26, Issue 2

Abstract

Atypical Parkinsonian syndromes include multiple systems atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and dementia with Lewy bodies (DLB). These conditions show signs of dopamine deficiency, but unlike Parkinson’s disease (PD), they do not respond to dopaminergic treatments and usually have a worse outcome compared with idiopathic PD. The Atypical Parkinsonian syndromes have no specific treatment or cure. Up to now, there are just a few therapeutic approaches that place emphasis on symptomatic and supportive therapies. These approaches are based on palliative care, physical or occupational therapy, neuropsychology, speech pathology, psychiatry, and social works. Pharmacotherapy with levodopa, dopamine agonists, amantadine, co-enzyme Q10, botulinum toxin, cholinesterase inhibitors, and selective serotonin reuptake inhibitors may improve some symptoms of PSP and CBD. In this review, we categorize some of the recent studies on therapeutic strategies as follows: autologous transplantation of stem cells, deep transcranial magnetic stimulation, intravenous immunoglobulin, intranasal insulin, and pimavanserin. By classifying and comparing the most recent advances in treatment strategies of the atypical parkinsonian syndromes, we provide a benchmark for further studies to introduce new effective therapeutic methods.

Authors and Affiliations

Mehdi Maghbooli, Vida Mohammadzadeh, Mehran Yousefi

Keywords

Related Articles

Cockayne Syndrome as a Rare Cause of Hemiplegia: Review of the Literature Accompanied by a Case Report

Cockayne syndrome is a rare genetic disease that presents with growth retardation, premature aging, retinal and generalized neurologic abnormalities. The presented case is a 29-year-old male patient, who was previously d...

Reliability and Validity of the Turkish Version of the Mini-BESTest Balance Scale in Patients with Stroke

Objective: To determine the validity and reliability of the Turkish version of the Mini-BESTest balance scale (Mini-BESTest-Turk) and provide a culturally adapted version for use in Turkish patients with stroke. Materia...

The Relation Between Serum P-selectin, Thrombin-activatable Fibrinolysis Inhibitor Levels, and Carotid Artery Intima-media Thickness in Acute Ischemic Stroke

Objective: Inflammation and migration of leukocytes to the brain parenchyma play a role in atherosclerosis and cerebral ischemic stroke. Migration occurs with the help of adhesion molecules on the surface of cerebral end...

Download PDF file
  • EP ID EP685138
  • DOI 10.4274/tnd.2020.45467
  • Views 201
  • Downloads 0

How To Cite

Mehdi Maghbooli, Vida Mohammadzadeh, Mehran Yousefi (2020). Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes. Turkish Journal of Neurology, 26(2), -. https://europub.co.uk/articles/-A-685138